Publicacións (110) Publicacións de María del Mar Tomás Carmona

2024

  1. Improving phage therapy by evasion of phage resistance mechanisms

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 1

  2. Mitomycin C as an Anti-Persister Strategy against Klebsiella pneumoniae: Toxicity and Synergy Studies

    Antibiotics, Vol. 13, Núm. 9

  3. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

    Nature Microbiology, Vol. 9, Núm. 6, pp. 1434-1453

  4. Phages produce persisters

    Microbial Biotechnology, Vol. 17, Núm. 8

  5. Regulation of anti-phage defense mechanisms by using cinnamaldehyde as a quorum sensing inhibitor

    Frontiers in Microbiology, Vol. 15

  6. Simultaneous clonal spread of NDM-1–producing Pseudomonas aeruginosa ST773 from Ukrainian patients in the Netherlands and Spain

    IJID Regions, Vol. 12

  7. Single-cell analysis reveals that cryptic prophage protease LfgB protects Escherichia coli during oxidative stress by cleaving antitoxin MqsA

    Microbiology spectrum, Vol. 12, Núm. 2, pp. e0347123

  8. The role of viral diagnostic tests in respiratory tract infections: moving forward

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 252-256

  9. Toxin/antitoxin systems induce persistence and work in concert with restriction/modification systems to inhibit phage

    Microbiology spectrum, Vol. 12, Núm. 1, pp. e0338823

  10. Use of Galleria mellonella as an Animal Model for Studying the Antimicrobial Activity of Bacteriophages with Potential Use in Phage Therapy

    Methods in Molecular Biology (Humana Press Inc.), pp. 171-180

2023

  1. CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases

    Microbiology spectrum, Vol. 11, Núm. 4, pp. e0132923

  2. Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection

    Frontiers in Medicine, Vol. 10

  3. Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages

    Frontiers in Microbiology, Vol. 14

  4. Prophage identification and molecular analysis in the genomes of Pseudomonas aeruginosa strains isolated from critical care patients

    mSphere, Vol. 8, Núm. 4, pp. e0012823

  5. Prophage identification and molecular analysis in the genomes of Pseudomonas aeruginosa strains isolated from critical care patients

    mSphere

  6. Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae

    Microbiology Spectrum, Vol. 11, Núm. 2

  7. Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in Pseudomonas aeruginosa

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  8. Ribosome inactivation by Escherichia coli GTPase RsgA inhibits T4 phage

    Frontiers in Microbiology, Vol. 14

  9. Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1272-1281